Document Detail


Crystallization of free cholesterol in model macrophage foam cells.
MedLine Citation:
PMID:  10446067     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
-The present study examined free cholesterol (FC) crystallization in macrophage foam cells. Model foam cells (J774 or mouse peritoneal macrophages [MPMs]) were incubated with acetylated low density lipoprotein and FC/phospholipid dispersions for 48 hours, resulting in the deposition of large stores of cytoplasmic cholesteryl esters (CEs). The model foam cells were then incubated for up to 5 days with an acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor (CP-113,818) in the absence of an extracellular FC acceptor to allow intracellular accumulation of FC. FC crystals of various shapes and sizes formed in the MPMs but not in the J774 macrophages. Examination of the MPM monolayers by microscopy indicated that the crystals were externalized rapidly after formation and thereafter continued to increase in size. Incubating J774 macrophages with 8-(4-chlorophenylthio)adenosine 3':5'-cyclic monophosphate (CPT-cAMP) in addition to CP-113,818 caused FC crystal formation as a consequence of CPT-cAMP stimulation of CE hydrolysis and inhibition of cell growth. In addition, 2 separate cholesterol phases (liquid-crystalline and cholesterol monohydrate) in the plane of the membrane bilayer were detected after 31 hours of ACAT inhibition by the use of small-angle x-ray diffraction of J774 macrophage foam cells treated with CPT-cAMP. Other compounds reported to inhibit ACAT, namely progesterone (20 microgram/mL) and N-acetyl-D-sphingosine (c(2)-ceramide, 10 microgram/mL), induced cellular toxicity in J774 macrophage foam cells and FC crystallization when coincubated with CPT-cAMP. Addition of the extracellular FC acceptors apolipoproteins (apo) E and A-I (50 microgram/mL) reduced FC crystal formation. In MPMs, lower cell density and frequent changes of medium were conducive to crystal formation. This may be due to "dilution" of apoE secreted by the MPMs and is consistent with our observation that the addition of exogenous apoE or apoA-I inhibits FC crystal formation in J774 macrophage foam cells cotreated with CP-113,818 plus CPT-cAMP. These data demonstrate that FC crystals can form from the hydrolysis of cytoplasmic stores of CEs in model foam cells. FC crystal formation can be modulated by the addition of extracellular FC acceptors or by affecting the cellular rate of CE hydrolysis. This process may contribute to the formation of FC crystals in atherosclerotic plaques.
Authors:
G Kellner-Weibel; P G Yancey; W G Jerome; T Walser; R P Mason; M C Phillips; G H Rothblat
Related Documents :
19602037 - A prospective study of macrophage migration inhibitory factor as a marker of inflammato...
14620137 - Macrophage migration inhibitory factor and host innate immune responses to microbes.
17442617 - Pro-inflammatory action of ldl(-) on mononuclear cells is counteracted by increased il1...
16778967 - Inhibitory effects of blocking voltage-dependent potassium channel 1.3 on human monocyt...
16343117 - Effect of mineral trioxide aggregate on cytokine production by peritoneal macrophages.
20958317 - Responding to infection and apoptosis--a task for th17 cells.
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Arteriosclerosis, thrombosis, and vascular biology     Volume:  19     ISSN:  1079-5642     ISO Abbreviation:  Arterioscler. Thromb. Vasc. Biol.     Publication Date:  1999 Aug 
Date Detail:
Created Date:  1999-08-24     Completed Date:  1999-08-24     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  9505803     Medline TA:  Arterioscler Thromb Vasc Biol     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  1891-8     Citation Subset:  IM    
Affiliation:
Department of Biochemistry, MCP Hahnemann University, Philadelphia, PA,USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Apolipoproteins / pharmacology
Cell Line
Cholesterol / chemistry*
Crystallization
Crystallography, X-Ray
Cytotoxicity, Immunologic / drug effects
Foam Cells / chemistry*
Macrophages, Peritoneal / cytology*
Mice
Sterol O-Acyltransferase / antagonists & inhibitors
X-Ray Diffraction / methods
Grant Support
ID/Acronym/Agency:
HL07443/HL/NHLBI NIH HHS; HL22633/HL/NHLBI NIH HHS; R01-HL49148/HL/NHLBI NIH HHS
Chemical
Reg. No./Substance:
0/Apolipoproteins; 57-88-5/Cholesterol; EC 2.3.1.26/Sterol O-Acyltransferase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Uptake of oxidized LDL by macrophages differs from that of acetyl LDL and leads to expansion of an a...
Next Document:  Dysfunction of nitric oxide mediation in isolated rat arterioles with methionine diet-induced hyperh...